<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html><!-- #BeginTemplate "/Templates/pressrelease.dwt" --><!-- DW6 -->
<head>
<!-- #BeginEditable "doctitle" -->
<title>FDA Approves First Insulin Drug for Diabetic Dogs</title>
<script type="text/javascript" src="/fsrscripts/triggerParams.js"></script> 
<script type="text/javascript" src="/fsrscripts/stdLauncher.js"></script>
<script type="text/javascript">Poll();</script>

<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<meta http-equiv="Content-language" content="en">
<meta name="keywords" content="insulin, diabetic, dogs, porcine insulin zinc suspension,  diabetes, ">
<meta name="description" content="FDA Approves First Insulin Drug for Diabetic Dogs">
<meta name="Posted" content="05-04-2004">
<meta name="Poster" content="jch">
<meta name="updated" content="">
<link href="/stylesheets/news.css" rel="stylesheet" type="text/css">
<style type="text/css">
<!--
@media print {
.contacts { font-size: 8pt; }
}
.skip, .skip a:link, .skip a:visited, .skip a:hover, .skip a:active { font-size: 0px; margin: 0px; padding: 0px; line-height: 0px; font-weight: normal;}
-->
</style>
<!-- #EndEditable -->
</head>

<body>
<div class="skip"> <a href="#top"><img src="/graphics/dot_clear.gif" alt="Skip Navigation" border="0" width="1" height="1"></a> 
</div>
<table width="100%" border="0" cellspacing="0" cellpadding="0" align="center">
<tr>
<td height="68" class="hedbackground"><a href="/default.htm"><img src="/graphics/mastheadart/images/fda_mast_01.gif" alt="FDA Logo--links to FDA home page" height="68" width="100" border="0"></a></td>
<td height="68"  class="hedbackground">
<div class="center">
<a href="/default.htm"><img src="/graphics/mastheadart/images/fda_mast_02.gif" alt="U.S. Food and Drug Administration" height="68" width="383" align="top" border="0"></a></div>
</td>
<td align="right" valign="middle" height="68"  class="hedbackground"><a href="http://www.hhs.gov/"><img src="/graphics/mastheadart/images/fda_mast_03.gif" alt="HHS Log--links to Department of Health and Human Services website" height="68" width="116" border="0"></a></td>
</tr>
</table>
		
<p class="header"><a href="/default.htm">FDA Home Page</a> | <a href="/search.html">Search
    FDA Site</a> 
  | <a href="/opacom/hpchoice.html">FDA A-Z Index</a> | <a href="/comments.html">Contact
   FDA</a></p>
<p><img src="/graphics/blkpixel.gif" alt="horizontal rule" height="1" width="100%" border="0"></p>

<a name="top"></a><h1>FDA News</h1>
		<table cellspacing=0 cellpadding=0 width="100%" border=0>
<tr> 
    <td width="67%"> <!-- #BeginEditable "Press Release Number/Date" --> 
      <p> FOR IMMEDIATE RELEASE<br>
        P04-50<br>
        May 4, 2004</p>
      <!-- #EndEditable --></td>
<td width="33%"> 
      <p class="contacts">Media Inquiries: <!-- #BeginEditable "Media Inquiries Phone Number" -->301-827-6242<!-- #EndEditable --><br>
        Consumer Inquiries: 888-INFO-FDA</p></td>
  </tr>
</table>
		<br>
		
<h2><!-- #BeginEditable "H2 Title Head" -->FDA Approves First Insulin Drug for
    Diabetic Dogs<!-- #EndEditable --></h2>
		
<!-- #BeginEditable "Body of Text" -->
<p> FDA has approved a porcine insulin zinc suspension product as the first drug
  for treating diabetic dogs. Prior to the development of this product, the only
  treatment veterinarians could use on diabetic dogs was human insulin, which
is less compatible with a dog&rsquo;s metabolic system. </p>


<p> Estimates are that one in every 200 dogs will develop diabetes. The onset
  usually occurs in dogs aged 7-9 years, and seems to be twice as prevalent in
  females as in males. </p>
<p> &ldquo;This is a very positive development for millions of American dog owners
  and their pets,&rdquo; said Acting FDA Commissioner Dr. Lester M. Crawford. &ldquo;It
  promises to improve the health and quality of life of dogs who suffer from
  this debilitating disease.&rdquo; </p>
<p> The product will be marketed under the trade name &ldquo;Vetsulin&rdquo; by
  its developer Intervet, Inc. of Millsboro, Del., and will be available under
  a veterinarian&rsquo;s prescription. </p>
<p> The treatment will be used to improve the clinical signs of diabetes in dogs
  such as excessive thirst, excessive urination, excessive appetite, and weight
  loss despite good appetite. </p>
<p> Veterinarians will determine the initial treatment dose based on the dog&rsquo;s
  weight, and then will use various tests to adjust the dosage to the optimum
  level. </p>
<p> Maintenance administration of the insulin may be done in the home. Dog owners
  will be provided instructions on how to treat their dogs at home with the insulin.
  An information sheet that outlines the benefits and risks of the treatment
  will also be provided. </p>
<p> Among the risks dog owners may face is hypoglycemia (dangerously low<b></b>blood
  sugar) if they accidentally inject themselves with the insulin. The product
  contains warning statements on the label about this risk as well as others
  such as the need to prevent eye exposure to the insulin. </p>
<p> Vetsulin has already been approved in 20 countries, including the United
  Kingdom, and should be available in the United States in late summer 2004.</p>
<p align="center">#### </p>
<!-- #EndEditable -->

<p><img src="/graphics/blkpixel.gif" alt="rule" height="1" width="100%" border="0"></p>

<p class="footer"><a href="/opacom/moremedia.html">Media Contacts</a> &nbsp; | &nbsp; <a href="/opacom/hpwhats.html">FDA News Page</a> <br>
<a href="/default.htm">FDA Home Page</a> | <a href="/search.html">Search FDA
Site</a> | <a href="/opacom/hpchoice.html">FDA A-Z Index</a> | <a href="/comments.html">Contact
FDA</a> | <a href="/privacy.html">Privacy</a> | <a href="http://www.hhs.gov/Accessibility.html">Accessibility</a></p>
<p class="footer">  <!-- #BeginEditable "Office" --><a href="/comments.html">FDA Website
      Management Staff</a><!-- #EndEditable -->
</body>
<!-- #EndTemplate --></html>


